These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1995881)

  • 21. N3-methyl-mafosfamide as a chemically stable, alternative prodrug of mafosfamide.
    Moon KY; Kwon CH
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1673-8. PubMed ID: 9873412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenylalanyl-aminocyclophosphamides as model prodrugs for proteolytic activation: synthesis, stability, and stereochemical requirements for enzymatic cleavage.
    Jiang Y; Hu L
    Bioorg Med Chem Lett; 2007 Jan; 17(2):517-21. PubMed ID: 17064897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, base-catalyzed hydrolytic reactivity, and anticancer evaluation of O-aryl phosphorodiamidates as a novel class of pro(phosphorodiamidic acid mustards).
    Chiu FT; Tsui FP; Zon G
    J Med Chem; 1979 Jul; 22(7):802-7. PubMed ID: 448679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
    Struck RF; Dykes DJ; Corbett TH; Suling WJ; Trader MW
    Br J Cancer; 1983 Jan; 47(1):15-26. PubMed ID: 6821629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protonation of phosphoramide mustard and other phosphoramides.
    Gamcsik MP; Ludeman SM; Shulman-Roskes EM; McLennan IJ; Colvin ME; Colvin OM
    J Med Chem; 1993 Nov; 36(23):3636-45. PubMed ID: 8246232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 31P NMR and chloride ion kinetics of alkylating monoester phosphoramidates.
    Fries KM; Borch RF
    J Med Chem; 1991 Feb; 34(2):565-9. PubMed ID: 1995878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleotide derivatives of 2,7-diaminomitosene.
    Iyengar BS; Dorr RT; Remers WA; Kowal CD
    J Med Chem; 1988 Aug; 31(8):1579-85. PubMed ID: 3397995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation.
    Jiang Y; Han J; Yu C; Vass SO; Searle PF; Browne P; Knox RJ; Hu L
    J Med Chem; 2006 Jul; 49(14):4333-43. PubMed ID: 16821793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of novel quinone phosphorodiamidate prodrugs targeted to DT-diaphorase.
    Flader C; Liu J; Borch RF
    J Med Chem; 2000 Aug; 43(16):3157-67. PubMed ID: 10956224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, activation, and cytotoxicity of aldophosphamide analogues.
    Borch RF; Valente RR
    J Med Chem; 1991 Oct; 34(10):3052-8. PubMed ID: 1920356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antitumor properties of activated cyclophosphamide analogues.
    Borch RF; Canute GW
    J Med Chem; 1991 Oct; 34(10):3044-52. PubMed ID: 1920355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Covalent sequestration of phosphoramide mustard by metallothionein--an in vitro study.
    Wei D; Fabris D; Fenselau C
    Drug Metab Dispos; 1999 Jul; 27(7):786-91. PubMed ID: 10383921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of 1-aldofosfamide-perhydrothiazines.
    Zimmermann J; Bauer HH; Hohorst HJ; Voelcker G
    Arzneimittelforschung; 2000 Sep; 50(9):843-7. PubMed ID: 11050703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of a phosphoramide mustard-nucleotide adduct that is not by alkylation at the N7 position of guanine.
    Maccubbin AE; Caballes L; Chheda GB; Struck RF; Gurtoo HL
    Biochem Biophys Res Commun; 1989 Sep; 163(2):843-50. PubMed ID: 2783126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.
    Friedman OM; Wodinsky I; Myles A
    Cancer Treat Rep; 1976 Apr; 60(4):337-46. PubMed ID: 1277209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and structure-activity relationships of nitrobenzyl phosphoramide mustards as nitroreductase-activated prodrugs.
    Hu L; Wu X; Han J; Chen L; Vass SO; Browne P; Hall BS; Bot C; Gobalakrishnapillai V; Searle PF; Knox RJ; Wilkinson SR
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3986-91. PubMed ID: 21620697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of pteroic acid-conjugated nitroheterocyclic phosphoramidates as folate receptor-targeted alkylating agents.
    Steinberg G; Borch RF
    J Med Chem; 2001 Jan; 44(1):69-73. PubMed ID: 11141089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
    Yuan ZM; Smith PB; Brundrett RB; Colvin M; Fenselau C
    Drug Metab Dispos; 1991; 19(3):625-9. PubMed ID: 1680629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
    Low JE; Borch RF; Sladek NE
    Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Fluoro- and 5-chlorocyclophosphamide: synthesis, metabolism, and antitumor activity of the cis and trans isomers.
    Foster AB; Jarman M; Kinas RW; van Maanen JM; Taylor GN; Gaston JL; Parkin A; Richardson AC
    J Med Chem; 1981 Dec; 24(12):1399-403. PubMed ID: 7310816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.